Therapeutics Market: Type 2 Diabetes Industry 2019 Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019

2013-09-24
Published : Sep-2013

The report “Type 2 Diabetes Market to 2019 – A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019” by GBI Research is now available at RnRMarketResearch.com.com. Contact [email protected] with report name in subject line and your contact details to purchase this report or get your questions answered.

“Type 2 Diabetes Market to 2019 – A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019”. There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Over the forecast period from 2012 to 2019, the safer, more efficacious newer classes of drug (GLP-1 agonists, DPP-4 Inhibitors and SGLT-2 inhibitors) are expected to capture substantial market shares, largely replacing older classes such as sulfonylureas and thiazolidinediones. Additionally, a variety of novel drugs belonging to these newer classes are due to enter the market, and are expected to offer a moderate improvement in terms of efficacy and safety. The price of these new therapies is expected to be high, but this is unlikely to hinder their uptake. As a result, as well as an overall increase in the prevalent population, GBI Research believes that the value of the global market has the potential to grow to reach $38.8 billion by 2019.

Complete report available @ http://www.rnrmarketresearch.com/type-2-diabetes-market-to-2019-a-shifting-treatment-algorithm-and-intensified-competition-expected-to-drive-growth-by-2019-market-report.html .

Scope

– A brief introduction to type 2 diabetes, including the symptoms, pathogenesis, risk factors and diagnosis

– In-depth analysis of major glucose-lowering drugs for type 2 diabetes, including analyses of their safety, efficacy, treatment patterns, strengths/weaknesses and overall commercial prospects. Includes a heat map comparing major drugs in terms of safety, efficacy and dosing parameters.

– Comprehensive review of the pipeline for type 2 diabetes therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule types and molecular targets.

– Additional in-depth analysis of pipeline drug clinical trials by phase, molecule type, trial size, trial duration and program failure rate analyses for each molecule type and mechanism of action

– Multi-scenario forecast data for the market up to 2019, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs, and changes in disease epidemiology across key developed markets including the US, Japan, Germany, the UK, France, Italy and Spain

– Discussion of the drivers and barriers for market growth

Request a sample copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=116959 .

Reasons to Buy

– Understand the many different types of type 2 diabetes therapies on the market, from the older, established classes of treatment to newer, moderately superior types of drug, and their positions in the treatment algorithm

– Understand the strengths and weaknesses of each product

– Understand the scope of the pipeline, including which molecule types and mechanisms of action are prominent

– Observe trends in clinical trial duration and size amongst clinical phases and molecule types, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for type 2 diabetes therapeutics

– Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the type 2 diabetes therapeutics market.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116959 .

Browse more reports on Diabetes Drugs Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/diabetes-drugs .

Filed in: Diagnostics, Medical Device, Pharmaceutical, Therapeutics
Tags: 
More Reports
Title Price Buy Now

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) – Global Forecast to 2027

“Increasing prevalence of infectious diseases and the rising funding for R&D are driving the overall growth of the infectious disease diagnostics market” The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR. Market is driven by factors such as indication of infectious diseases, growing trend in POC testing and rising technological advancements. However, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the forecasted years. “The reagents, kits, and consumables accounted for the largest market share in the infectious disease diagnostics market, by product & service, during the forecast period” The infectious disease diagnostics......
 $4950

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027

“The global in vitro toxicology testing market is projected to grow at a CAGR of 10.8%.” The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%.Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market “The ADME segment is expected to account for the largest market share in 2021.” Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endp......
 $4950

Molecular Diagnostics Market by Product & Service (Reagents, Kits, Instruments), Test Type (Lab, PoC), Technology (PCR, INAAT, NGS, ISH), Application (Infectious, Oncology, Genetic Testing), End User (Diagnostic Labs, Hospitals) – Global Forecast to 2027

“Rising funding for R&D in molecular diagnostics and increasing prevalence of infectious diseases and cancer are driving the overall growth of the molecular diagnostics market” The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious diseases and cancer. On the other hand, an unfavorable reimbursement scenario and the high cost of instruments may restrain the growth of this market to a certain extent. “The DNA sequencing & NGS segment accounted for the highest growth rate in the molec......
 $4950

Laboratory Proficiency Testing Market by Industry (Clinical Chemistry, Hematology), Food & Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Microbiology, Water, Environmental) by Technology (PCR) – Global Forecast to 2026

“The rising an essential precondition for operational excellence and accreditation in several industries is expected to drive the overall growth of the laboratory proficiency testing market.” The global laboratory proficiency testing market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.4%. With proficiency testing being a mandatory procedure to be undertaken by laboratories functioning in different industries which are under regulation by organizations such as the CLIA, APLAC, and CLSI, the market for proficiency testing is expected to witness significant growth during the forecast period. PT forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the gro......
 $4950

Liquid Handling System Market by Product (Pipettes, Consumables, Microplate Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, Software), Type, Application, End User and Region – Global Forecast to 2026

“The Liquid Handling System market is projected to grow at CAGR of 5.1% from 2021 to 2026” The global liquid handling systems market is expected to reach USD 5.1 billion by 2026 from USD 4.0 billion in 2021, at a CAGR of 5.1% during the forecast period. The growth of this market is majorly driven by industrial growth in the pharma-biotech sector, rising R&D expenditure by biopharma companies, and growing life science research, supported by a favorable funding scenario. However, the slow adoption of automation among small and medium-sized laboratories may restrain the market growth. “Pipettes in the product segment to witness the highest growth during the forecast period.” Based on the products, the global liquid handling system market is segmented into Pipettes, Consum......
 $4950

In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2026

The global IVD market is projected to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. The growth of the IVD market is mainly driven by the rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated and POC instruments in developed regions, growing awareness regarding diseases diagnosis in developing regions, and growing R&D investments by industry players to launch new IVD products. Also, the development of disease-specific markers and tests is expected to offer potential growth opportunities to market players in the coming years. However, the unfavorable reimbursement scenario is expected to restrain the growth of this market during the f......
 $4950

Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027

“Dearth of skilled laboratory technicians” The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where the patient is located (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid and reliable diagnostic testing through which outcomes can be obtained instantly, helping physicians/patients to make decisions related to care remotely and as soon as possible. Market growth is mainly driven by the high prevalence of infectious diseases, supportive government p......
 $4950

Organ Preservation Market by Solution (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) – Global Forecast to 2026

The organ preservation market is expected to grow at a CAGR of 6.6% in the forecast period. The global organ preservation market is projected to reach USD 317 million by 2026 from USD 270 million in 2021, at a CAGR of 6.6%.Growth in this market is majorly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, concerns related to the high cost of organ transplantations and religious concerns in specific geographies are expected to limit the growth of this market to a certain extent. “The University of Wisconsin (UW) holds the largest market share in the solution market.” Based on the Solution, the segment is divided ......
 $4950

Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) – Global Forecast to 2026

The medical refrigerators market was valued at USD 3.5 Billion in 2020 and is projected to reach USD 4.9 Billion by 2026, at a CAGR of 6.0% during the forecast period. The medical refrigerators market is on course for intense growth across different end use industries such as blood banks, pharmaceutical companies, hospitals, & pharmacies, research institutes, medical laboratories, and diagnostic centers. “The ultra-low temperature freezers segment, by value, is projected to grow at the highest CAGR during the forecast period” By product type, ultra-low temperature freezers segment is expected to grow at the highest CAGR during 2021 to 2026, by value. Ultra-low temperature freezers (ULT freezers) are used for the storage of drugs, enzymes, chemicals, bacteria, viruses, cell pr......
 $4950

Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) – Global Forecast to 2026

“Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. On the other hand, stringent and time-consuming regulatory policies that significantly increase the product launch cycle may challenge market gr......
 $4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy